Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Buying Sensata Technologies Holding N.V. (NYSE:ST)

Sensata Technologies Holding N.V. (NYSE:ST) investors should pay attention to an increase in hedge fund sentiment lately.

To the average investor, there are plenty of methods investors can use to track their holdings. A couple of the most useful are hedge fund and insider trading movement. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the top hedge fund managers can outperform the market by a very impressive margin (see just how much).


Just as key, optimistic insider trading sentiment is another way to parse down the marketplace. Just as you’d expect, there are plenty of stimuli for an executive to get rid of shares of his or her company, but only one, very obvious reason why they would buy. Several empirical studies have demonstrated the market-beating potential of this method if shareholders understand where to look (learn more here).

Keeping this in mind, it’s important to take a gander at the recent action surrounding Sensata Technologies Holding N.V. (NYSE:ST).

How are hedge funds trading Sensata Technologies Holding N.V. (NYSE:ST)?

Heading into 2013, a total of 34 of the hedge funds we track were long in this stock, a change of 36% from one quarter earlier. With hedge funds’ sentiment swirling, there exists a select group of notable hedge fund managers who were boosting their stakes significantly.

When looking at the hedgies we track, Scout Capital Management, managed by James Crichton and Adam Weiss, holds the largest position in Sensata Technologies Holding N.V. (NYSE:ST). Scout Capital Management has a $336 million billion position in the stock, comprising 5.8% of its 13F portfolio. On Scout Capital Management’s heels is Blue Ridge Capital, managed by John Griffin, which held a $256 million position; the fund has 3.6% of its 13F portfolio invested in the stock. Other peers that are bullish include Bain Capital’s Brookside Capital, Alan Fournier’s Pennant Capital Management and Daniel S. Och’s OZ Management.

As one would reasonably expect, some big names were breaking ground themselves. Brookside Capital, managed by Bain Capital, created the biggest position in Sensata Technologies Holding N.V. (NYSE:ST). Brookside Capital had 206 million invested in the company at the end of the quarter. William B. Gray’s Orbis Investment Management also made a $23 million investment in the stock during the quarter. The other funds with brand new ST positions are Glenn J. Krevlin’s Glenhill Advisors, Richard S. Meisenberg’s ACK Asset Management, and Alexander Mitchell’s Scopus Asset Management.

How have insiders been trading Sensata Technologies Holding N.V. (NYSE:ST)?

Insider purchases made by high-level executives is most useful when the primary stock in question has experienced transactions within the past six months. Over the latest six-month time frame, Sensata Technologies Holding N.V. (NYSE:ST) has seen zero unique insiders purchasing, and 10 insider sales (see the details of insider trades here).

With the results demonstrated by our studies, retail investors must always monitor hedge fund and insider trading activity, and Sensata Technologies Holding N.V. (NYSE:ST) applies perfectly to this mantra.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!